Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate
Central Ohio
Change Location

READ NOW: Scientists expand research into Alzheimer’s disease to diversify treatments

READ NOW: Scientists expand research into Alzheimer’s disease to diversify treatments
Share or Print this page
Share or Print this page
September 23, 2019
Email:
Share or Print this page

READ NOW: Scientists expand research into Alzheimer’s disease to diversify treatments

One lesson: Timing might matter. Most of the failed anti-amyloid drugs were tested in people who already had at least mild symptoms. Some studies seeking to prevent memory loss in the first place still are underway. Several anti-tau drugs also are being tested.
Another lesson: Most people have a mix of dementias, which means they’ll need a variety of treatments.
“Now we have an opportunity — a real opportunity — to expand and try all these avenues,” said Alzheimer’s Association chief science officer Maria Carrillo.

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events

The first survivor of Alzheimer's is out there, but we won't get there without you.

Donate Now

Learn how Alzheimer’s disease affects the brain.

Take the Brain Tour

Don't just hope for a cure. Help us find one. Volunteer for a
clinical trial.

Learn More